Hemodyne

Hemodyne, Inc. is a medical technology company specializing in the development of advanced diagnostic tools for blood coagulation and hemostasis. The company's flagship product, the Hemodyne Hemostasis Analyzer (HHA), provides a comprehensive 'Global Hemostasis Profile' by measuring the mechanical properties of blood clots in real-time. Unlike traditional coagulation assays, Hemodyne's technology evaluates the functional interaction between platelets and the fibrin network, offering unique metrics such as platelet contractile force and clot elastic modulus. This platform is primarily utilized in clinical research and specialized surgical settings to improve the management of bleeding risks and the monitoring of antithrombotic treatments. The company's focus remains on providing high-resolution data to improve patient outcomes in hematology and critical care.